Safety Study of JTT-302 in Subjects With Low HDL-C Levels
Clinical trial NCT00748852 · COMPLETED
Trial details
- NCT number
- NCT00748852
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-03-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.